Table 3.

Univariate associations between initial symptoms and outcomes

Initial symptoms	Adverse outcomea; no. (%)	P value	Time to resolution of viral shedding, median (IQR), d	P value
Cough
No	2 (4.4)	.30	18 (4–86)	.21
Yes	7 (11.5)		23 (4–45)
Fatigue
No	7 (9.9)	.71	23 (4–50)	.92
Yes	2 (5.7)		21 (4–86)
Fever
No	1 (2.2)	.07	21 (4–86)	.64
Yes	8 (13.3)		23 (4–50)
Headache
No	6 (7.3)	.42	21 (4–86)	.11
Yes	3 (12.5)		25 (7–44)
Any sinus symptoms
No	8 (9.4)	.68	19 (4–50)	.04
Yes	1 (4.8)		26 (7–86)
Ageusia
No	9 (10.3)	.36	20 (4–50)	.04
Yes	0		27 (10–86)
Gastrointestinal symptoms
No	8 (9.3)	.99	20 (4–45)	.09
Yes	1 (5.0)		24 (10–86)
Myalgia
No	8 (10.7)	.28	20 (4–45)	.05
Yes	1 (3.2)		26 (4–86)
Anosmia
No	9 (10.3)	.36	21 (4–50)	.20
Yes	0		26 (9–86)
Shortness of breath
No	6 (6.4)	.06	21 (4–86)	.43
Yes	3 (25.0)		24 (12–44)

IQR interquartile range

^aAdverse outcome was defined as an emergency department visit or hospitalization.